are produced naturally in the lung and are essential for normal respiratory function and survival.
function to decrease the surface tension of lung alveoli so that they remain open and functional upon exhalation.
Discovery believes that through its technology, pulmonary surfactants
have the potential, for the first time, to be developed into a series of respiratory therapies for critical care and other hospitalized patients where there are few or no approved therapies available.
During this period]' his research on pulmonary surfactants
further illuminated the ways in which surfactants are produced by lung cells, their importance in normal pulmonary function, and how they interact with chemicals and hormones.
6013619 entitled "Novel Pulmonary Surfactants
and Therapeutics Uses, Including Pulmonary Lavage.
Discovery Labs previously secured worldwide exclusive rights to the CAG technology for use with all pulmonary surfactants
, alone or in combination with other pharmaceutical compounds, for a wide range of respiratory disorders.
Discovery believes that through its surfactant technology, pulmonary surfactants
have the potential, for the first time, to be developed into a series of respiratory therapies for hospitalized and ambulatory patients.